05:30 PM EDT, 05/01/2025 (MT Newswires) -- Ascendis Pharma ( ASND ) reported a Q1 diluted loss late Thursday of 1.58 euros ($1.78) per share, narrowing from a loss of 2.30 euros a year earlier.

Analysts polled by FactSet expected a loss of 1.47 euros.

Revenue for the quarter ended March 31 was 101 million euros, up from 95.9 million euros a year earlier.

Analysts surveyed by FactSet expected 94.9 million euros.